Myriad Medical, LLC, is pleased to announce a next step for the advancement of Brachytherapy in the treatment of Prostate Cancer, as the U.S….
Read moreThe International Journal of Medical Robotics and Computer Assisted Surgery published a study by Hatiboglu et al from the University of Heidelberg…
Read moreWith an estimated 180,890 new cases and 26,120 deaths related to the disease in 2016, prostate cancer has the highest incidence rate (21%) and the…
Read moreSince the 1960s, external beam radiation therapy (ERBT) has been one of the primary treatment modalities for localized prostate cancer management…
Read moreEvidence suggests that external beam radiation therapy (ERBT) is a well-warranted treatment modality for prostate cancer, and 51.7% to 53.1% of…
Read moreExternal beam radiotherapy has been widely accepted as an efficient treatment modality for localized prostate cancer, with dose escalated…
Read moreCompared to other treatment options, including brachytherapy, chemotherapy, and prostatectomy, external beam radiation therapy (ERBT) has been…
Read more